South London Neurology Ltd 12096762 false 2023-08-01 2024-07-31 2024-07-31 The principal activity of the company is to be specialists medical practice. Digita Accounts Production Advanced 6.30.9574.0 true 12096762 2023-08-01 2024-07-31 12096762 2024-07-31 12096762 core:CurrentFinancialInstruments core:WithinOneYear 2024-07-31 12096762 bus:Micro-entities 2023-08-01 2024-07-31 12096762 bus:AuditExemptWithAccountantsReport 2023-08-01 2024-07-31 12096762 bus:FullAccounts 2023-08-01 2024-07-31 12096762 bus:SmallCompaniesRegimeForAccounts 2023-08-01 2024-07-31 12096762 bus:RegisteredOffice 2023-08-01 2024-07-31 12096762 bus:Director1 2023-08-01 2024-07-31 12096762 bus:PrivateLimitedCompanyLtd 2023-08-01 2024-07-31 12096762 countries:England 2023-08-01 2024-07-31 12096762 2022-08-01 2023-07-31 12096762 2023-07-31 12096762 core:CurrentFinancialInstruments core:WithinOneYear 2023-07-31 iso4217:GBP xbrli:pure

Registration number: 12096762

South London Neurology Ltd

Annual Report and Unaudited Financial Statements

for the Year Ended 31 July 2024

 

South London Neurology Ltd

Contents

Balance Sheet

1 to 2

Notes to the Unaudited Financial Statements

1

 

South London Neurology Ltd

(Registration number: 12096762)
Balance Sheet as at 31 July 2024

2024
£

2023
£

Fixed assets

1,224

2,171

Current assets

86,139

58,963

Creditors: Amounts falling due within one year

(10,714)

(7,699)

Net current assets

75,425

51,264

Total assets less current liabilities

76,649

53,435

Accruals and deferred income

(1,513)

(1,513)

 

75,136

51,922

Capital and reserves

75,136

51,922

1

General information

The company is a private company limited by share capital, incorporated in England.

The address of its registered office is:
80-83 Long Lane
London
EC1A 9ET

These financial statements were authorised for issue by the Board on 18 November 2024.

Basis of preparation

The financial statements have been prepared under the historical cost convention and in accordance with FRS 105 'The Financial Reporting Standard applicable to the Micro-entities Regime'.

2

Staff numbers

The average number of persons employed by the company (including directors) during the year, was 2 (2023 - 2).

For the financial year ending 31 July 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the micro-entity provisions of the Companies Act 2006 and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

Approved and authorised by the Board on 18 November 2024 and signed on its behalf by:
 

 

South London Neurology Ltd

(Registration number: 12096762)
Balance Sheet as at 31 July 2024

.........................................
Jeremy Isaacs
Director